Login
Toggle sidebar

Lint: dermal-nerve-sheath-myxoma

dermal-nerve-sheath-myxoma
Strong List Colon Position
error

"T1: isointense compared to muscle"

Line 43:8 · When enboldening an intro, the colon should not be bold. '<strong>T1:</strong> isointense'

"T2: hyperintense"

Line 44:8 · When enboldening an intro, the colon should not be bold. '<strong>T2: </strong>hyperintense'

"T1 C+ (Gd): enhancement"

Line 45:8 · When enboldening an intro, the colon should not be bold. '<strong>T1 C+ (Gd): </strong>enhancement'
Acronyms
warning

"Neoplastic Schwann cells should be diffusely positive S100 and show reactivity to GFAP, and CD57 on immunohistochemistry stains. The surrounding fibrous connective tissue should respond to collagen IV 1-4."

Line 36:93 · 'GFAP' has no definition. Spell it out if it's unfamiliar to the audience.
Oxford Comma
suggestion

"The diagnosis of dermal nerve sheath myxoma is established by a combination of clinical, histological and immunohistochemical features 1."

Line 5:83 · Use the Oxford comma in 'clinical, histological and immunohistochemical'.

"form, location and size"

Line 50:8 · Use the Oxford comma in 'form, location and size'.
Biographical Lifespan
suggestion

"History and etymology"

Line 58:1 · A bold element in the History and etymology section should be a person; it would be useful to have their lifespan details: '<h4>History and etymology</h4> <p>Dermal nerve sheath myxomas were first reported in the literature by two American pathologists, <strong>James C. Harkin</strong> '
Links
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0